Price to Sales (P/S)
since 2005
Paying user area
Try for free
Edwards Lifesciences Corp. pages available for free this week:
- Statement of Comprehensive Income
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Selected Financial Data since 2005
- Return on Assets (ROA) since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Edwards Lifesciences Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Edwards Lifesciences Corp., P/S, long-term trends, calculation
| P/S | = | Share price1, 2, 3 | ÷ | Sales per share1 | Sales per share1 | = | Net sales1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 12, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 14, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 15, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 16, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 17, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 20, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2012 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2011 | = | ÷ | = | ÷ | |||||||
| Feb 26, 2010 | = | ÷ | = | ÷ | |||||||
| Mar 2, 2009 | = | ÷ | = | ÷ | |||||||
| Feb 29, 2008 | = | ÷ | = | ÷ | |||||||
| Mar 1, 2007 | = | ÷ | = | ÷ | |||||||
| Mar 9, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Edwards Lifesciences Corp. Annual Report.
The analysis of the annual financial data reveals notable upward trends in key performance metrics over the period examined.
- Share Price
- The share price exhibited significant growth from US$3.48 in 2006 to US$107.73 in 2022. The progression was generally consistent, with periodic accelerations such as the jump from US$11.63 in 2014 to US$22.41 in 2015, and continued increases thereafter. This steady appreciation indicates strong investor confidence and market valuation enhancement over the years.
- Sales per Share
- Sales per share increased steadily from US$1.40 in 2006 to US$8.40 in 2022. The trend reflects a sustained improvement in revenue generation on a per-share basis. The growth trajectory was relatively smooth, with notable incremental rises such as from US$3.87 in 2016 to US$5.45 in 2018. This suggests expanding operational performance and successful sales growth.
- Price-to-Sales Ratio (P/S)
- The P/S ratio moved upward from 2.48 in 2006 to 12.83 in 2022, indicating that the market valuation has increased faster than sales per share. After a period of fluctuation with a low near 2.27 in 2008 and highs around 6.75 in 2011, the ratio showed a strong rising trend post-2014, reaching a peak of 12.83 by 2022. This implies heightened market expectations and perceived growth potential relative to current sales levels.
Overall, the data portrays a company with steadily improving sales metrics coupled with a sharply rising equity market valuation. The accelerating P/S ratio towards the later years underscores investor optimism and possibly greater anticipated future growth or profitability. The alignment of growing sales per share and share price appreciation suggests effective translation of revenue gains into shareholder value.
Comparison to Competitors
Edwards Lifesciences Corp., P/S, long-term trends, comparison to competitors
| Edwards Lifesciences Corp. | Abbott Laboratories | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|
| Feb 14, 2022 | |||||||
| Feb 12, 2021 | |||||||
| Feb 14, 2020 | |||||||
| Feb 15, 2019 | |||||||
| Feb 16, 2018 | |||||||
| Feb 17, 2017 | |||||||
| Feb 19, 2016 | |||||||
| Feb 20, 2015 | |||||||
| Feb 28, 2014 | |||||||
| Feb 28, 2013 | |||||||
| Feb 27, 2012 | |||||||
| Feb 28, 2011 | |||||||
| Feb 26, 2010 | |||||||
| Mar 2, 2009 | |||||||
| Feb 29, 2008 | |||||||
| Mar 1, 2007 | |||||||
| Mar 9, 2006 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Edwards Lifesciences Corp., P/S, long-term trends, comparison to sector (health care equipment & services)
| Edwards Lifesciences Corp. | Health Care Equipment & Services | |
|---|---|---|
| Feb 14, 2022 | ||
| Feb 12, 2021 | ||
| Feb 14, 2020 | ||
| Feb 15, 2019 | ||
| Feb 16, 2018 | ||
| Feb 17, 2017 | ||
| Feb 19, 2016 | ||
| Feb 20, 2015 | ||
| Feb 28, 2014 | ||
| Feb 28, 2013 | ||
| Feb 27, 2012 | ||
| Feb 28, 2011 | ||
| Feb 26, 2010 | ||
| Mar 2, 2009 | ||
| Feb 29, 2008 | ||
| Mar 1, 2007 | ||
| Mar 9, 2006 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Edwards Lifesciences Corp., P/S, long-term trends, comparison to industry (health care)
| Edwards Lifesciences Corp. | Health Care | |
|---|---|---|
| Feb 14, 2022 | ||
| Feb 12, 2021 | ||
| Feb 14, 2020 | ||
| Feb 15, 2019 | ||
| Feb 16, 2018 | ||
| Feb 17, 2017 | ||
| Feb 19, 2016 | ||
| Feb 20, 2015 | ||
| Feb 28, 2014 | ||
| Feb 28, 2013 | ||
| Feb 27, 2012 | ||
| Feb 28, 2011 | ||
| Feb 26, 2010 | ||
| Mar 2, 2009 | ||
| Feb 29, 2008 | ||
| Mar 1, 2007 | ||
| Mar 9, 2006 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).